Vasculogenic mimicry
- PMID: 15563313
- DOI: 10.1111/j.1600-0463.2004.apm11207-0810.x
Vasculogenic mimicry
Abstract
The term vasculogenic mimicry describes the formation of fluid-conducting channels by highly invasive and genetically dysregulated tumor cells. Two distinctive types of vasculogenic mimicry have been described. Vasculogenic mimicry of the tubular type may be confused morphologically with endothelial cell-lined blood vessels. Vasculogenic mimicry of the patterned matrix type in no way resembles blood vessels morphologically or topologically. Matrix proteins such as laminin, heparan sulfate proteoglycan, and collagens IV and VI have been identified in these patterns. The patterned matrix anastomoses with blood vessels, and systemically injected tracers co-localize to these patterns. Vasculogenic mimicry of the patterned matrix type has been identified in uveal, cutaneous and mucous membrane melanomas, inflammatory and ductal breast carcinoma, ovarian and prostatic carcinoma, and soft tissue sarcomas, including synovial sarcoma rhabdomyosarcoma, osteosarcoma, and pheochromocytoma. Because the microcirculation of many tumors may be heterogeneous -- including incorporated or co-opted vessels, angiogenic vessels, mosaic vessels, and vasculogenic mimicry of the tubular and patterned matrix types -- therapeutic regimens that target angiogenesis alone may be ineffective against highly invasive tumors that contain patterned matrices. Vasculogenic mimicry provides an opportunity to investigate the interrelationships between the genetically dysregulated invasive tumor cell, the microenvironment, and the malignant switch.
Similar articles
-
[Vasculogenic mimicry--potential target for tumor therapy].Ai Zheng. 2006 Jul;25(7):914-6. Ai Zheng. 2006. PMID: 16831290 Review. Chinese.
-
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).Cancer Res. 2001 Apr 15;61(8):3250-5. Cancer Res. 2001. PMID: 11309274
-
Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.Nat Rev Cancer. 2003 Jun;3(6):411-21. doi: 10.1038/nrc1092. Nat Rev Cancer. 2003. PMID: 12778131 Review.
-
Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.Int J Oncol. 2004 Dec;25(6):1609-14. Int J Oncol. 2004. PMID: 15547697
-
Vasculogenic mimicry: current status and future prospects.Cancer Lett. 2007 Sep 8;254(2):157-64. doi: 10.1016/j.canlet.2006.12.036. Epub 2007 Feb 15. Cancer Lett. 2007. PMID: 17306454 Review.
Cited by
-
Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.J Huazhong Univ Sci Technolog Med Sci. 2012 Jun;32(3):346-352. doi: 10.1007/s11596-012-0060-4. Epub 2012 Jun 9. J Huazhong Univ Sci Technolog Med Sci. 2012. PMID: 22684556
-
Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry.Cancer Metastasis Rev. 2023 Mar;42(1):323-334. doi: 10.1007/s10555-023-10087-1. Epub 2023 Feb 8. Cancer Metastasis Rev. 2023. PMID: 36754910 Free PMC article. Review.
-
Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells.Cancers (Basel). 2022 Dec 15;14(24):6201. doi: 10.3390/cancers14246201. Cancers (Basel). 2022. PMID: 36551686 Free PMC article.
-
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.Neoplasia. 2018 Oct;20(10):1070-1082. doi: 10.1016/j.neo.2018.08.011. Neoplasia. 2018. PMID: 30236892 Free PMC article.
-
Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.Int J Mol Sci. 2017 Dec 8;18(12):2661. doi: 10.3390/ijms18122661. Int J Mol Sci. 2017. PMID: 29292756 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources